|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: BLONDER TONGUE LABORATORIES INC, 10-Q, EX-10.1, 2000-08-14 |
Next: ALKERMES CLINICAL PARTNERS LP, 10-Q, 2000-08-14 |
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THE SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM BLONDER
TONGUE LABORATORIES, INC. AND SUBSIDIARIES CONSOLIDATED STATEMENT OF EARNINGS
FOR THE SIX-MONTH PERIOD ENDED JUNE 30, 2000 AND BALANCE SHEET AS AT JUNE 30,
2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-END> JUN-30-2000
<CASH> 1,474
<SECURITIES> 0
<RECEIVABLES> 11,416
<ALLOWANCES> (912)
<INVENTORY> 27,971
<CURRENT-ASSETS> 43,521
<PP&E> 14,072
<DEPRECIATION> (6,072)
<TOTAL-ASSETS> 68,203
<CURRENT-LIABILITIES> 15,193
<BONDS> 0
0
0
<COMMON> 8
<OTHER-SE> 38,838
<TOTAL-LIABILITY-AND-EQUITY> 68,203
<SALES> 39,242
<TOTAL-REVENUES> 39,242
<CGS> 25,224
<TOTAL-COSTS> 25,224
<OTHER-EXPENSES> 7,512
<LOSS-PROVISION> 229
<INTEREST-EXPENSE> 1,106
<INCOME-PRETAX> 5,171
<INCOME-TAX> 1,838
<INCOME-CONTINUING> 3,333
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 3,333
<EPS-BASIC> .44
<EPS-DILUTED> .43
</TABLE>
|
|